The Movement: FDA mifepristone blow jolts anti-abortion strategy

To anti-abortion activists who worked diligently to help President Trump win in 2024 and deliver a Republican trifecta, the Food and Drug Administration’s (FDA) decision last week to approve a generic version of mifepristone — a pill used in medication abortions — was a slap in the face. The “pro-life” community is well aware that in the...